Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
About Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Göteborg University
2
Clinical Trials at Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
During the past decade, Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Polycystic Ovary Syndrome (PCOS) - Effect Of Physical Exercise And Electroacupuncture
2005-10-01
2008-10-01
Completed
84
Acupuncture and Gonadotropin-releasing Hormone Pulse Generator and Stress Axis in Polycystic Ovary Syndrome
2009-02-01
2010-12-01
Completed
28
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)
2022-04-19
2023-03-10
Terminated
24
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
According to Clinical.Site data, the most researched conditions in "Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry" are
"Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Polycystic Ovary Syndrome" (2 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry" in a lesser frequency.
Clinical Trials Intervention Types at Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
Most popular intervention types in "Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry" are "Drug" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Gantenerumab" (3 trials), "Crenezumab" (2 trials), "Electroacupuncture" (1 trials) and "Low-frequency electro-acupuncture (EA)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
The vast majority of trials in "Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry" are
5 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry
Currently, there are NaN active trials in "Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Sahlgrenska Academy University,Neuroscience and Physiology;Departmt of Psychiatry and Neurochemistry, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".